Recurrence and Survival in Patients With Merkel Cell Carcinoma Undergoing Surgery Without Adjuvant Radiation Therapy to the Primary Site-Reference-Cited by-同舟云学术

Recurrence and Survival in Patients With Merkel Cell Carcinoma Undergoing Surgery Without Adjuvant Radiation Therapy to the Primary Site

Published:2016-09-01 Issue:9 Volume:152 Page:1001
ISSN:2168-6068
Container-title:JAMA Dermatology
language:en
Short-container-title:JAMA Dermatol

Author:

Frohm Marcus L.¹,Griffith Kent A.²,Harms Kelly L.³,Hayman James A.⁴,Fullen Douglas R.⁵,Nelson Christine C.⁶,Wong Sandra L.⁷,Schwartz Jennifer L.³,Bichakjian Christopher K.³

Affiliation:

1. Department of Dermatology, University of Michigan Health System, Ann Arbor2Dermatology, Sanford Health, Sioux Falls, South Dakota

2. Center for Cancer Biostatistics, University of Michigan Health System, Ann Arbor

3. Department of Dermatology, University of Michigan Health System, Ann Arbor

4. Department of Radiation Oncology, University of Michigan Health System, Ann Arbor

5. Department of Pathology, University of Michigan Health System, Ann Arbor

6. Department of Ophthalmology and Visual Science, University of Michigan Health System, Ann Arbor

7. Department of Surgery, University of Michigan Health System, Ann Arbor

Publisher

American Medical Association (AMA)

Subject

Dermatology

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Merkel cell carcinoma and the eye;Clinics in Dermatology;2024-07

2. Postoperative Radiation Therapy Is Indicated for “Low-Risk” Pathologic Stage I Merkel Cell Carcinoma of the Head and Neck Region but Not for Other Locations;Advances in Radiation Oncology;2024-02

3. Imaging of Merkel cell carcinoma of the eyelid: A case report;Oncology Letters;2024-01-23

4. NCCN Guidelines® Insights: Merkel Cell Carcinoma, Version 1.2024;Journal of the National Comprehensive Cancer Network;2024-01

5. Adjuvant Radiation in Resectable Node-Positive Merkel Cell Carcinoma in the Immunotherapy Era: Implications for Future and Ongoing Trials;Cancers;2023-11-23